Related Experiment Video

Updated: Jan 2, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

480

Tolerogenic pDCs: spotlight on Foxo3

Vincenzo Bronte1

  • 1Verona University Hospital and Department of Pathology, Immunology Section, University of Verona, Verona, Italy. vincenzo.bronte@univr.it

The Journal of Clinical Investigation
|March 26, 2011
PubMed

Insights

Cancer promotes inflammation that suppresses adaptive immunity. Researchers found Foxo3 in plasmacytoid dendritic cells (pDCs) drives this tolerance, but CD4+ T cells can block Foxo3 to restore anti-tumor immunity.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Cancer establishes an inflammatory tumor microenvironment that suppresses adaptive anti-tumor immune responses.
  • Transcription factors play critical roles in regulating immune cell function within the tumor microenvironment.

Purpose of the Study:

  • To identify key regulators of immune tolerance induced by tumor-associated myeloid cells.
  • To elucidate the role of transcription factor Foxo3 in plasmacytoid dendritic cell (pDC)-mediated immune suppression in cancer.

Main Methods:

  • Analysis of transcription factor expression in tumor-associated myeloid cells.
  • Investigating the function of Foxo3 in pDCs using genetic and cellular assays.
  • Assessing the impact of pDC-mediated tolerance on CD8+ T cell function.
  • Evaluating the role of CD4+ T helper cells in modulating pDC function and Foxo3 expression.

Main Results:

  • Foxo3 was identified as a master regulator of the tolerogenic program in tumor-associated pDCs.
  • Foxo3-expressing pDCs induce tolerance in tumor antigen-specific CD8+ T cells, converting them into regulatory lymphocytes.
  • Tumor-specific CD4+ T helper cells inhibit Foxo3 expression in pDCs, thereby licensing their antigen-presenting capacity and anti-tumor activity.

Conclusions:

  • Foxo3 is a critical transcription factor mediating immune suppression by pDCs in the cancer microenvironment.
  • Targeting Foxo3 in pDCs represents a potential therapeutic strategy to enhance anti-tumor immunity.
  • Understanding the interplay of transcription factors in myeloid cells is crucial for developing novel cancer immunotherapies.

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K
Identifying Transcription Factor Olig2 Genomic Binding Sites in Acutely Purified PDGFRα+ Cells by Low-cell Chromatin Immunoprecipitation Sequencing Analysis12:29

Identifying Transcription Factor Olig2 Genomic Binding Sites in Acutely Purified PDGFRα+ Cells by Low-cell Chromatin Immunoprecipitation Sequencing Analysis

Published on: April 16, 2018

9.6K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.1K